% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • investingnideas investingnideas Jan 28, 2013 3:41 PM Flag

    Is Zerenex a problem for AFFY?

    " Results of Zerenex's Phase 3 trial showed the oral treatment not only was successful in lowering phosphate levels in patients with end-stage kidney disease but that it also reduced the use of intravenous iron by 52%. Roughly 70% to 80% of dialysis patients currently receive iron intravenously, the company said.

    The results also showed a 27% decline in the use of erythropoiesis-stimulating agents--which stimulate the bone marrow to produce red blood cells. "

    Sandy Hook investigation update 15a Police Radio, Parking, B. Sibley, LifeFlight, Code Silver

    Sentiment: Strong Buy

0.080.0000(0.00%)Oct 21 2:51 PMEDT